WHO ICTRP trial

Efficacy and Safety of Gwakjeongtang-gami for Diarrhea-Predominant Irritable…

KCT0008523 · Clinical Research Information Service (CRIS) · Not Recruiting

Key facts

Trial ID KCT0008523
Public title Efficacy and Safety of Gwakjeongtang-gami for Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Trial
Scientific title Efficacy and Safety of Gwakjeongtang-gami for Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Trial
Primary sponsor Kyung Hee University Oriental Medical Center
Registry Clinical Research Information Service (CRIS)
Recruitment status Not Recruiting
Study type Interventional Study
Phase Not applicable
Countries Korea, Republic of
Conditions Diseases of the digestive system
Interventions Drug : 1. Experimental group: Participants will receive modified Gwakjeongtang granules (10g) three times a day for a duration of 4 weeks. 2. Placebo group: Participants will receive placebo granules (10g) three times a day for a duration…
Registration date Jun 14, 2023
Target size 60
Registry page cris.nih.go.kr

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations